Agreed, Killer Nut.

In my more fristrated moments, i have even wondered whether that realization has slowed the trial until BETonMACE starts or something. 

On the optimistic side, this drug seems to have more potential indications than even its main targets. But if it cannot sustain maket interest, that may or may not matter.